These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28378857)

  • 1. Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate.
    Morita M; Takashima E; Ito D; Miura K; Thongkukiatkul A; Diouf A; Fairhurst RM; Diakite M; Long CA; Torii M; Tsuboi T
    Sci Rep; 2017 Apr; 7():46086. PubMed ID: 28378857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda.
    Kanoi BN; Takashima E; Morita M; White MT; Palacpac NM; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T
    Vaccine; 2017 Feb; 35(6):873-881. PubMed ID: 28089547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
    Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
    Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes.
    Sakamoto H; Takeo S; Maier AG; Sattabongkot J; Cowman AF; Tsuboi T
    Vaccine; 2012 Mar; 30(11):1972-80. PubMed ID: 22248820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.
    Miura K; Perera S; Brockley S; Zhou H; Aebig JA; Moretz SE; Miller LH; Doumbo OK; Sagara I; Dicko A; Ellis RD; Long CA
    PLoS One; 2011; 6(6):e20947. PubMed ID: 21695140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination.
    Miura K; Zhou H; Moretz SE; Diouf A; Thera MA; Dolo A; Doumbo O; Malkin E; Diemert D; Miller LH; Mullen GE; Long CA
    J Immunol; 2008 Dec; 181(12):8776-83. PubMed ID: 19050299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
    Laurens MB; Kouriba B; Bergmann-Leitner E; Angov E; Coulibaly D; Diarra I; Daou M; Niangaly A; Blackwelder WC; Wu Y; Cohen J; Ballou WR; Vekemans J; Lanar DE; Dutta S; Diggs C; Soisson L; Heppner DG; Doumbo OK; Plowe CV; Thera MA
    PLoS One; 2017; 12(3):e0173294. PubMed ID: 28282396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigen.
    Ito D; Hasegawa T; Miura K; Yamasaki T; Arumugam TU; Thongkukiatkul A; Takeo S; Takashima E; Sattabongkot J; Han ET; Long CA; Torii M; Tsuboi T
    Infect Immun; 2013 Nov; 81(11):4290-8. PubMed ID: 24002067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission.
    Sakamoto H; Takeo S; Takashima E; Miura K; Kanoi BN; Kaneko T; Han ET; Tachibana M; Matsuoka K; Sattabongkot J; Udomsangpetch R; Ishino T; Tsuboi T
    Parasitol Int; 2018 Apr; 67(2):203-208. PubMed ID: 29217416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.
    Willcox AC; Huber AS; Diouf A; Barrett JR; Silk SE; Pulido D; King LDW; Alanine DGW; Minassian AM; Diakite M; Draper SJ; Long CA; Miura K
    Cell Rep Med; 2021 Jul; 2(7):100326. PubMed ID: 34337556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.
    Malkin EM; Diemert DJ; McArthur JH; Perreault JR; Miles AP; Giersing BK; Mullen GE; Orcutt A; Muratova O; Awkal M; Zhou H; Wang J; Stowers A; Long CA; Mahanty S; Miller LH; Saul A; Durbin AP
    Infect Immun; 2005 Jun; 73(6):3677-85. PubMed ID: 15908397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
    Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
    J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen.
    Arumugam TU; Takeo S; Yamasaki T; Thonkukiatkul A; Miura K; Otsuki H; Zhou H; Long CA; Sattabongkot J; Thompson J; Wilson DW; Beeson JG; Healer J; Crabb BS; Cowman AF; Torii M; Tsuboi T
    Infect Immun; 2011 Nov; 79(11):4523-32. PubMed ID: 21896773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stage-specific in vitro efficacy of a malaria antigen cocktail provides valuable insights into the development of effective multi-stage vaccines.
    Spiegel H; Boes A; Kastilan R; Kapelski S; Edgue G; Beiss V; Chubodova I; Scheuermayer M; Pradel G; Schillberg S; Reimann A; Fischer R
    Biotechnol J; 2015 Oct; 10(10):1651-9. PubMed ID: 25913888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.